3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
27
Myelodysplastic Syndromes
6
Leukemia, Biphenotypic, Acute
4
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid
2
Leukemia
2
Blast Crisis
2
Sarcoma, Myeloid
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Carcinoma, Hepatocellular
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
trastuzumab deruxtecan
1
sacituzumab govitecan
1
Temozolomide
1
Social Determinants of Health
1
Methylprednisolone
1
Irinotecan
1
Cefixime
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Idarubicin
×
90 days
×
Clear all
No trials found.